All posts

The IPO Window Opens Wide While Liquidity Drains Beneath It

North Watch · ·9 min read
A contemporary skyscraper facade with reflective glass panels, symbolizing the corporate public listings arriving on exchanges this week.
Photo by Jan van der Wolf on PexelsPhoto by nappy on Pexels

The IPO market has not been this active in years. SK hynix raised $26.5 billion in the largest foreign IPO in US history[1]. CXMT just priced an $8.6 billion Shanghai listing — Asia’s biggest of 2026[2]. Jersey Mike’s is mid-roadshow for a $1 billion NYSE debut[3]. Scribe Therapeutics upsized and priced at the high end[4]. The issuance pipeline is open, and deals are getting done.

But underneath the headline activity, the plumbing is tightening. Roughly $120 billion of Treasury bill settlements hit July 28–31, draining reserves from the system[5]. The dispersion trade that drove single-stock selection for months is beginning to fade as earnings season passes its peak[5]. Concentration in the S&P 500 sits near record highs, with the ten largest companies accounting for nearly 40% of the index and semiconductors alone representing nearly one-fifth[6]. The IPO window is open — but the liquidity that keeps it open is being pulled in two directions at once.

The Issuance Surge: Big Deals, Mixed Aftermarket

The headline number is SK hynix. The Korean memory giant priced 177.9 million ADRs at $149 each on July 9, raising approximately $26.5 billion and surpassing Alibaba’s 2014 record for the largest foreign IPO ever in the United States[1]. The ADRs (ticker SKHY) opened at $170 on Nasdaq — a 14% pop — and currently trade around $154.57, up 3.7% from the offer price[7]. For context, that single deal is larger than the entire US IPO market raised in some full quarters of the post-2022 drought.

Ticker Company Offer Date Deal Size ($M) Current Price Return from IPO
SCTX Scribe Therapeutics 07/23/26 $129 $21.65 +44.3%
QMLS QumulusAI 07/16/26 — $7.16 −45.3%
CSQR Csquare 07/15/26 $1,050 $22.77 +8.4%
STDN Standard Nuclear 07/15/26 $150 $8.30 −44.7%
SKHY SK hynix 07/09/26 $26,507 $154.57 +3.7%
BSP Bending Spoons 06/30/26 $1,681 $34.06 +17.5%
SPCX SpaceX 06/11/26 $75,000 $115.07 −14.8%
QNT Quantinuum 06/03/26 $1,680 $52.29 −12.9%

Source: Renaissance Capital pricings data, as of July 26, 2026[7]

The pattern is bifurcated. Quality names with clear narratives — Scribe Therapeutics (CRISPR gene editing, backed by Sanofi and Nobel laureate Jennifer Doudna[4]) and Bending Spoons (+17.5%) — are rewarding IPO investors. But the smaller, less-established deals are getting punished: QumulusAI is down 45%, Standard Nuclear down 45%, and SpaceX itself remains 15% below its June offer price[7]. The market is not rejecting IPOs. It is being selective, and the gap between winners and losers is widening.

Two more deals are in the immediate pipeline:

  • Jersey Mike’s Subs (JMKE): Blackstone-backed sandwich chain with 3,000+ US locations, offering 43.5 million Class A shares at $21–$25, targeting ~$1 billion at the midpoint. The deal is 68% secondary — existing shareholders (including Blackstone) are cashing out roughly $742 million[3]. Expected NYSE debut: July 30.
  • CXMT Corp: The world’s fourth-largest DRAM maker raised 57.92 billion yuan ($8.6 billion) at 8.66 yuan per share, valuing the company at roughly $85.5 billion[2]. Only 6.73% of the enlarged share capital is freely tradable at listing, which could magnify price swings. The Shanghai STAR Market debut is July 27.

The CXMT float is worth watching closely. With only 6.73% of shares tradable, HSBC Qianhai warned the listing could drain liquidity from the broader Chinese market before and on its debut day[2]. A small free float combined with a sharp tech selloff in the preceding days creates conditions for violent first-day moves in either direction.

The Liquidity Drain: $120 Billion in T-Bill Settlements

While the IPO calendar fills up, the system is quietly tightening. The week of July 28 brings a concentrated wave of Treasury bill settlements — $70.5 billion on July 28, $38.5 billion on July 30, and $11.6 billion on July 31 — totaling roughly $120 billion over three days[5]. This is not a new phenomenon; T-bill settlements have been draining liquidity all year. But the concentration into a single week, overlapping with heavy earnings (Microsoft and Meta on July 29, Apple and Amazon on July 30) and a Federal Reserve decision on July 29, creates a convergence of potential pressure points.

Business newspaper with financial headlines

The historical record is not comforting: T-bill settlement days have been positive for the S&P 500 only 45.7% of the time, with an average return of roughly −23 basis points[5]. The mechanism is straightforward — when capital flows into Treasuries, it flows out of risk assets. And with T-bill issuance continuing to build through September, this drain is not a one-week event[5].

Simultaneously, the dispersion trade that dominated the market for weeks is beginning to unwind. Single-stock implied volatility has been falling as companies report earnings, narrowing the gap between individual-stock vol and index vol that made the trade profitable[5]. As that spread compresses, correlation among stocks tends to rise — and historically, periods when the dispersion-implied correlation spread narrows have coincided with weaker S&P 500 performance[5].

The Structural Backdrop: Concentration, Leverage, and the Retail Bid

Citadel Securities’ 1H 2026 Market Structure review, published June 30, framed the environment with unusual clarity: “The defining story of the first half of 2026 was not a macro shock, it was the continued structural transformation of equity markets”[6]. Several data points from that review are directly relevant to the IPO-liquidity tension:

Concentration at record highs. The ten largest S&P 500 companies now represent nearly 40% of the index. Semiconductor companies alone account for roughly 20% — the highest share on record, quadrupling since June 2020[6]. When a single sector dominates to this degree, new issuance in that sector (SK hynix, CXMT) competes for the same pool of concentrated capital.

Passive flows at unprecedented pace. ETFs attracted $1.2 trillion in net inflows year-to-date through June, running 45% ahead of last year’s record pace[6]. This is a structural bid for existing large-cap stocks — not for new IPOs, which typically enter indices only after they meet size and liquidity thresholds. The passive machine buys what is already in the index; IPOs must earn their way in.

Retail as the structural bid. Average daily retail cash equity volumes in May and June ran 65% above 2025 levels, with June 12 marking the largest single day of retail net buying on Citadel’s platform[6]. Retail buy-the-dip behavior reached a new extreme — 3.5x the average daily purchase amount on SPX down days[6]. Retail is a persistent source of demand, but it is concentrated in the same leadership sectors (semiconductors, broad ETFs) rather than in new issues.

Leverage migrating to the short-dated. One in three listed options now expires the same day. Nearly half of retail options volume is in 0DTE contracts. Leveraged ETF assets reached a record ~$218 billion, up 60% since March alone[6]. This leverage amplifies moves in the underlying market, including in newly public companies with thin floats.

Volatility in a new regime. Three-month implied correlations fell to their lowest level in over 15 years — a stock picker’s market[6]. But semiconductor implied volatility has doubled over the past decade, from 32% in 2016 to nearly 72% today[6]. The same sector driving new issuance (SK hynix, CXMT, Quantinuum) is the sector with the most elevated volatility. New issues in high-IV sectors face an audience that is already paying premium for optionality.

Buybacks: The Quiet Counterweight

While the IPO calendar draws the headlines, corporate buybacks continue to absorb supply at a steady clip. Several programs were announced or extended in the past week:

  • Flagstar Bank (FLG): $250 million repurchase authorization, announced July 24[8]
  • S&T Bancorp (STBA): $100 million repurchase program, replacing existing authorization effective July 27[8]
  • Equinor: Third tranche of up to $1.125 billion under its 2026 buyback program, commencing July 23[8]
  • RELX: £150 million non-discretionary programme running July 23 through September 4, following the completion of a prior £100 million programme[8]
  • Alimentation Couche-Tard: Renewed NCIB announced July 16[8]

These are not headline-grabbing numbers individually, but collectively they represent a persistent demand source that offsets some of the supply pressure from new issuance. The buyback machine does not make the news the way a $26.5 billion IPO does — but it is a structural feature of US equity markets that Citadel Securities’ framework places alongside passive flows and retail activity as a defining force[6].

What to Watch Next

  1. CXMT’s Shanghai debut (July 27) — With only 6.73% free float and a $85.5 billion valuation, the first-day price action will be a gauge of appetite for Chinese semiconductor exposure after a sharp tech pullback. HSBC Qianhai warned it could drain liquidity from the broader market[2].

  2. Jersey Mike’s NYSE debut (July 30) — A $1 billion consumer IPO pricing into a market dominated by tech and semiconductor leadership. The 68% secondary component means existing shareholders are the primary beneficiaries — watch whether that dampens aftermarket demand[3].

  3. $120B T-bill settlement wave (July 28–31) — The liquidity drain coincides with mega-cap earnings (Microsoft, Meta on July 29; Apple, Amazon on July 30) and a Fed decision on July 29. The convergence of these three forces — issuance absorption, liquidity drain, and earnings-driven volatility — is the week’s central tension[5].

  4. Dispersion trade unwind — As more companies report, the gap between single-stock and index implied volatility should continue to compress. If correlation rises and dispersion falls, the environment that favored stock selection shifts toward one where broad index moves dominate — a regime change with implications for both new issuance pricing and existing portfolio positioning[5].

  5. SpaceX and recent IPO performance — SpaceX remains 15% below its $75 billion June offer price[7]. The performance of recent large deals — SK hynix (+3.7%), Bending Spoons (+17.5%), SpaceX (−14.8%) — will shape underwriter confidence for the fall IPO calendar. If the bifurcation between winners and losers continues to widen, pricing discipline will tighten.

The IPO window is open. The question is not whether deals can get done — they clearly can, and at scale. The question is whether the liquidity backdrop can absorb them without strain, and whether the structural forces reshaping market behavior (concentration, passive dominance, retail leverage, 0DTE) amplify or dampen the impact of new supply. The week of July 28 is when several of these threads converge at once.

Sources

  1. 424(B)(4)sec.gov
  2. China memory chipmaker CXMT set for Shanghai debut after Asia's biggest IPO | MarketScree…hk.marketscreener.com
  3. S-1/Asec.gov
  4. Scribe Therapeutics Announces Pricing of Upsized Initialglobenewswire.com
  5. Liquidity Headwinds Build as Dispersion Trade Begins to Fademottcapitalmanagement.com
  6. 1H 2026 Market Structure & Flows - Citadel Securitiescitadelsecurities.com
  7. 2026 Recently Priced IPOsrenaissancecapital.com
  8. share buyback programs announcements July 2026sec.gov